JP2001518304A - アンギオスタチン成分を含む融合タンパク質及び抗腫瘍療法におけるその使用 - Google Patents
アンギオスタチン成分を含む融合タンパク質及び抗腫瘍療法におけるその使用Info
- Publication number
- JP2001518304A JP2001518304A JP2000513958A JP2000513958A JP2001518304A JP 2001518304 A JP2001518304 A JP 2001518304A JP 2000513958 A JP2000513958 A JP 2000513958A JP 2000513958 A JP2000513958 A JP 2000513958A JP 2001518304 A JP2001518304 A JP 2001518304A
- Authority
- JP
- Japan
- Prior art keywords
- seq
- protein
- multifunctional protein
- angiostatin
- interferon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6060997P | 1997-10-01 | 1997-10-01 | |
| US60/060,609 | 1997-10-01 | ||
| PCT/US1998/020464 WO1999016889A1 (en) | 1997-10-01 | 1998-09-30 | Fusion proteins comprising an angiostatin moiety and their use in anti-tumor treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001518304A true JP2001518304A (ja) | 2001-10-16 |
| JP2001518304A5 JP2001518304A5 (cg-RX-API-DMAC7.html) | 2006-01-05 |
Family
ID=22030604
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000513958A Withdrawn JP2001518304A (ja) | 1997-10-01 | 1998-09-30 | アンギオスタチン成分を含む融合タンパク質及び抗腫瘍療法におけるその使用 |
Country Status (5)
| Country | Link |
|---|---|
| EP (2) | EP1019515A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2001518304A (cg-RX-API-DMAC7.html) |
| AU (1) | AU9673998A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2303401A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO1999016889A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999029856A1 (en) * | 1997-12-08 | 1999-06-17 | Beth Israel Deaconess Medical Center | Restin and methods of use thereof |
| US6797488B1 (en) | 1997-12-08 | 2004-09-28 | Beth Israel Deaconess Medical Center | Methods of producing anti-angiogenic proteins |
| WO1999061464A1 (en) * | 1998-05-28 | 1999-12-02 | Korea Green Cross Corporation | Process of purifying angiogenesis inhibitors |
| US6500431B1 (en) * | 1998-07-13 | 2002-12-31 | University Of Southern California | Inhibitors of angiogenesis and tumor growth |
| CA2367375A1 (en) * | 1999-03-15 | 2000-09-21 | Chiron Corporation | Use of recombinant gene delivery vectors for treating or preventing diseases of the eye |
| US6943153B1 (en) | 1999-03-15 | 2005-09-13 | The Regents Of The University Of California | Use of recombinant gene delivery vectors for treating or preventing diseases of the eye |
| AU2004240199B2 (en) * | 1999-04-30 | 2007-05-17 | Novartis Vaccines And Diagnostics S.R.L. | Conserved Neisserial antigens |
| AU2001238499A1 (en) * | 2000-02-18 | 2001-08-27 | New York Medical College | Nitroacridine/tumor inhibitor compositions |
| AU8591901A (en) | 2000-09-05 | 2002-03-22 | Karolinska Innovations Ab | Materials and methods relating to endothelial cell growth inhibitors |
| DE60134885D1 (de) * | 2000-11-28 | 2008-08-28 | David M Waisman | Antiangiogene polypeptide |
| US20030086903A1 (en) | 2001-11-02 | 2003-05-08 | Genvec, Inc. | Therapeutic regimen for treating cancer |
| US20030158112A1 (en) | 2002-02-15 | 2003-08-21 | Johns Hopkins University School Of Medicine | Selective induction of apoptosis to treat ocular disease |
| WO2003093303A1 (en) | 2002-05-06 | 2003-11-13 | Board Of Regents, The University Of Texas System | Targeting proteins to deliver therapeutic or diagnostic reagents |
| JP4511108B2 (ja) * | 2002-05-31 | 2010-07-28 | オンコリクス インコーポレイテッド | ヒトプロラクチン拮抗剤−血管新生阻害剤融合蛋白質 |
| CA2514873C (en) | 2002-12-13 | 2012-01-03 | David Waisman | Compositions and methods for inhibiting tumor growth and metastasis |
| WO2008124086A2 (en) * | 2007-04-05 | 2008-10-16 | President And Fellows Of Harvard College | Chimeric activators: quantitatively designed protein therapeutics and uses thereof |
| EP2628748A1 (en) | 2012-02-14 | 2013-08-21 | Szilak Laboratories Bioinformatics & Molecule-Design Ltd. | Angiostatin chimeras and uses thereof |
| TWI698240B (zh) | 2012-05-15 | 2020-07-11 | 澳大利亞商艾佛蘭屈澳洲私營有限公司 | 使用腺相關病毒(aav)sflt-1治療老年性黃斑部退化(amd) |
| ES2686968T3 (es) * | 2013-05-06 | 2018-10-23 | China Pharmaceutical University | Proteínas de fusión bifuncionales para inhibir la angiogénesis en el microambiente tumoral y para activar las respuestas inmunitarias adaptativas y los genes y usos de las mismas |
| ES2822551T3 (es) | 2014-03-17 | 2021-05-04 | Adverum Biotechnologies Inc | Composiciones y métodos para la expresión génica mejorada en células de los conos |
| WO2015168474A1 (en) | 2014-04-30 | 2015-11-05 | President And Fellows Of Harvard College | Fusion proteins for treating cancer and related methods |
| FI3265178T3 (fi) | 2015-03-02 | 2026-08-03 | Adverum Biotechnologies Inc | Koostumuksia ja menetelmiä polynukleotidien viemiseksi intravitreaalisesti retinaalisiin tappisoluihin |
| GB2545763A (en) | 2015-12-23 | 2017-06-28 | Adverum Biotechnologies Inc | Mutant viral capsid libraries and related systems and methods |
| CN114058636A (zh) * | 2021-11-16 | 2022-02-18 | 大连润生康泰医学检验实验室有限公司 | 一种转甲状腺素蛋白基因的克隆、表达与纯化方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8315980D0 (en) * | 1983-06-10 | 1983-07-13 | Biogen Nv | Producing hybrid dna sequences |
| IL86909A0 (en) * | 1987-07-01 | 1988-11-30 | Beecham Group Plc | Hybrid plasminogen activator,dna coding therefor,derivatives of said plasminogen activator and pharmaceutical compositions containing said plasminogen activator or said derivatives |
| AU1674292A (en) * | 1991-03-15 | 1992-10-21 | Synergen, Inc. | Pegylation of polypeptides |
| CN1636594B (zh) * | 1994-04-26 | 2012-08-29 | 儿童医学中心公司 | 血管生成抑制素和用于抑制血管生成的方法 |
| MX9708217A (es) * | 1995-04-26 | 1997-12-31 | Childrens Medical Center | Fragmentos de angiostatina y angiostatina agregada y metodos de uso. |
| US5824299A (en) * | 1995-06-22 | 1998-10-20 | President & Fellows Of Harvard College | Modulation of endothelial cell proliferation with IP-10 |
| EP0857210B1 (en) * | 1995-10-23 | 2003-09-03 | The Children's Medical Center Corporation | Therapeutic antiangiogenic compositions and methods |
| US5837680A (en) * | 1996-02-16 | 1998-11-17 | Children's Medical Center Corporation | Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis |
| JP2002523036A (ja) * | 1998-08-25 | 2002-07-30 | レキシジェン ファーマシューティカルズ コーポレイション | イムノフュージンとしての新脈管形成インヒビターの発現および輸送 |
-
1998
- 1998-09-30 WO PCT/US1998/020464 patent/WO1999016889A1/en not_active Ceased
- 1998-09-30 JP JP2000513958A patent/JP2001518304A/ja not_active Withdrawn
- 1998-09-30 AU AU96739/98A patent/AU9673998A/en not_active Abandoned
- 1998-09-30 EP EP98950775A patent/EP1019515A1/en not_active Withdrawn
- 1998-09-30 CA CA002303401A patent/CA2303401A1/en not_active Abandoned
- 1998-09-30 EP EP05019787A patent/EP1705248A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999016889A1 (en) | 1999-04-08 |
| EP1705248A1 (en) | 2006-09-27 |
| AU9673998A (en) | 1999-04-23 |
| EP1019515A1 (en) | 2000-07-19 |
| CA2303401A1 (en) | 1999-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1705248A1 (en) | Fusion proteins comprising an angiostatin moiety and their use in anti-tumour treatment | |
| RU2240328C2 (ru) | Гомодимерный слитый белок, имеющий активность ингибитора ангиогенеза (варианты), молекула днк, кодирующая гомодимерный слитый белок, вектор для экспрессии гомодимерного слитого белка, способ трансфекции клетки млекопитающего и способ получения гомодимерного слитого белка | |
| KR100336452B1 (ko) | 앤지오스타틴및맥관형성억제를위한이의사용방법 | |
| CN1087344C (zh) | 转化生长因子α-H1 | |
| JP4295831B2 (ja) | 改変された腫瘍壊死因子 | |
| JPH11509187A (ja) | 内皮細胞増殖の調節 | |
| AU749904B2 (en) | Restin and methods of use thereof | |
| US20050063948A1 (en) | Methods for targeting interleukin-12 to malignant endothelium | |
| CN100543036C (zh) | 递送治疗或诊断试剂的导向蛋白质 | |
| AU784359B2 (en) | Compositions and methods for inhibiting endothelial cell proliferation | |
| US6797488B1 (en) | Methods of producing anti-angiogenic proteins | |
| JP2002516261A (ja) | セリンプロテアーゼを利用して内皮細胞増殖を阻害し血管新生を調節するための組成物と方法 | |
| EP1268798B1 (en) | Anti-angiogenic properties of vascostatin and fragments or variants thereof | |
| AU781134B2 (en) | Methods for treating tumors using antiangiogenic compounds | |
| EP1268783B1 (en) | Antiangiogene Eigenschaften von Matin und Fragmenten oder Varianten davon | |
| JP2000508531A (ja) | 細胞外/上皮増殖因子様タンパク質 | |
| RO118299B1 (ro) | Polipeptida trombopoietina, secventa adn care o codifica, procedeu pentru prepararea polipeptidei trombopoietine si compozitie farmaceutica cu aceasta | |
| US20040121945A1 (en) | Compositions and methods for inhibiting endothelial cell proliferation | |
| US20030077818A1 (en) | Compositions and methods for targeting interleukin-12 to malignant endothelium | |
| AU2001287274B2 (en) | Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains | |
| JP2000506371A (ja) | 成長因子htter36 | |
| US20030119739A1 (en) | Anti-angiogenic and anti-tumor properties of Vascostatin and other nidogen domains | |
| AU2001287274A1 (en) | Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains | |
| JP2006087443A (ja) | トランスフォーミング増殖因子αHII | |
| JP2009100747A (ja) | トランスフォーミング増殖因子αHII |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050930 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050930 |
|
| A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20061012 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070307 |